Press Office

Latest Press Releases
15/03/10	EMA	Mylan S.A.S. withdraws its marketing authorisation for Docetaxel Mylan (docetaxel)
12/03/10	CVMP	Press Release from the March meeting
11/03/10	EMA	Ark Therapeutics Ltd withdraws its marketing authorisation application for Cerepro (sitimagene ceradenovec)
05/03/10	COMP	Monthly report from the March meeting Correction (published 15/03/10)
26/02/10	COMP	FDA and EMA Agree to Accept a Single Orphan Drug Designation Annual Report
25/02/10	CHMP	Monthly report from the February meeting
24/02/10	CVMP	Monthly report from the February meeting
24/02/10	PDCO	Monthly report from the 17-19 February meeting
22/02/10	EMA	Monthly report from the CAT February meeting
19/02/10	EMA	United Therapeutics Europe Ltd withdraws its marketing authorisation application for Tyvaso
19/02/10	CHMP	Press Release from the CHMP February meeting
19/02/10	EMA	European Medicines Agency updates on pandemic influenza
18/02/10	EMA	European Medicines Agency recommends contraindication for Regranex in patients with any pre-existing cancer - See also: Questions and Answers
17/02/10	EMA	European Medicines Agency publishes eleventh weekly pandemic pharmacovigilance report
16/02/10	EMA	European Medicines Agency and EUnetHTA Joint Action start collaboration on European Public Assessment Report (EPAR) contribution to relative effectiveness assessments
15/02/10	EMA	European Medicines Agency and Swissmedic agree sharing of information on H1N1 pandemic medicines
12/02/10	CVMP	Press Release from the February meeting
10/02/10	COMP	Monthly report from the February meeting Correction (published 24/02/10)
10/02/10	CVMP	Monthly report from the January meeting
10/02/10	EMA	European Medicines Agency publishes tenth weekly pandemic pharmacovigilance report
03/02/10	EMA	European Medicines Agency publishes ninth weekly pandemic pharmacovigilance report
02/02/10	HMPC	Meeting report from the HMPC January meeting